Skip to main content
. 2024 Sep 2;29(4):e24spe4. doi: 10.1590/2177-6709.29.4.e24spe4

Table 2: Drug therapy proposal according to each TMJ OA stage.

Phenotype Oral drugs Intra-articular injection
Adaptive x X
Cartilage erosive Glucosamine + Chondroitin Hyaluronic acid
Bone erosion x I-PRF
Secondary inflammation Undenatured Type II Collagen Hyaluronic acid
Primary effusion NSAIDs Corticosteroids

I-PRF = injectable platelet rich fibrin; NSAIDs =Non-steroidal anti-inflammatory drugs.